Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


IN-STENT ARTERIAL RESTENOSIS side effect

What is IN-STENT ARTERIAL RESTENOSIS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   IN-STENT ARTERIAL RESTENOSIS and Recently Reported Side Effects   IN-STENT ARTERIAL RESTENOSIS and 15 most Active Side Effect polls   IN-STENT ARTERIAL RESTENOSIS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with IN-STENT ARTERIAL RESTENOSIS

ANGIOMAX  AVONEX  ISCOVER  PLAVIX  REOPRO  


Plavix Side Effects Report #5622292-3
Consumer or non-health professional from UNITED STATES reported PLAVIX problem on Sept 28, 2007. Male patient, 63 years of age, was diagnosed with stent placement and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, . PLAVIX dosage: 75 MG QD - ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, SIMVASTATIN. Patient recovered.

Avonex Side Effects Report #5443102-3
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, 50 years of age, weighting 180.0 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, influenza like illness, myocardial infarction, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Reopro Side Effects Report #5339699-4
Physician from GERMANY reported REOPRO problem on May 22, 2007. Male patient, 63 years of age, was treated with REOPRO. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, . REOPRO dosage: unknown. During the same period patient was treated with CLOPIDOGREL, HEPARIN, ASPIRIN. Patient recovered.

Angiomax Side Effects Report #5290213-1
ANGIOMAX problem was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, pain in jaw, post procedural complication, thrombosis in device, . ANGIOMAX dosage: unknown. During the same period patient was treated with PLAVIX, INTEGRILIN. Patient recovered.


Angiomax Side Effects Report #5304901-1
Health Professional from UNITED STATES reported ANGIOMAX problem on Apr 02, 2007. Female patient was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, pain in jaw, stent occlusion, thrombosis in device, . ANGIOMAX dosage: 75 MG/KG, BOLUS, IV BOLUS,. During the same period patient was treated with PLAVIX, INTEGRILIN. Patient recovered.

Angiomax Side Effects Report #5583734-5
ANGIOMAX problem was reported by a Consumer or non-health professional from ISRAEL on Dec 18, 2007. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: angina unstable, in-stent arterial restenosis, . ANGIOMAX dosage: unknown. During the same period patient was treated with ASPIRIN, SPIRONOLACTONE, ATORVASTATIN CALCIUM, ATENOLOL, LOSEC, ENALAPRIL MALEATE, PLAVIX. Patient was hospitalized. Patient recovered.

Iscover Side Effects Report #5542457-9
Physician from GERMANY reported ISCOVER problem on Nov 28, 2007. Male patient, weighting 149.9 lb, was diagnosed with coronary angioplasty, stent placement and was treated with ISCOVER. After drug was administered, patient experienced the following problems/side effects: in-stent arterial restenosis, . ISCOVER dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Angiomax Side Effects Report #5273349-0
ANGIOMAX problem was reported by a Physician from ARGENTINA on Dec 11, 2006. Male patient, 55 years of age, weighting 205.0 lb, was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: angina unstable, blood creatine phosphokinase increased, in-stent arterial restenosis, . ANGIOMAX dosage: unknown. Patient recovered.

Angiomax Side Effects Report #5290053-3
Physician from ARGENTINA reported ANGIOMAX problem on Mar 19, 2007. Male patient, 55 years of age, weighting 205.0 lb, was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: angina unstable, coronary revascularisation, in-stent arterial restenosis, . ANGIOMAX dosage: 69 MG, BOLUS, IV BOLUS. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about IN-STENT ARTERIAL RESTENOSIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about IN-STENT ARTERIAL RESTENOSIS